HPS Laboratories Private Limited
About HPS Laboratories Private Limited
Data last updated:
HPS Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2006PTC049581.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.62 Cr. It is led by directors including Vishnuvardhan Reddy Devireddy and Mallikarjuna Reddy Venati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No: 41 Phase – II I.D.A Mallapur, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.36 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹57.72 Lakh (net margin -2.5%) and EBITDA of ₹70 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
Its group structure includes 2 subsidiaries.
As per MCA filings, the company has satisfied charges of ₹3.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
HPS Laboratories has one previous CIN (Corporate Identification Number): U24239AP2006PTC049581. The current CIN is U24239TG2006PTC049581, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2006PTC049581 | Current |
| U24239AP2006PTC049581 | Previous |
Contact details
HPS Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No: 41 Phase – II I.D.A Mallapur, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of HPS Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of HPS Laboratories Private Limited
FY 2025 filings availableHPS Laboratories Private Limited reported revenue of ₹23.36 Cr (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 3% fall in the latest year. EBITDA rose 755% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹57.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | -2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of HPS Laboratories Private Limited, buy the company report.
Board of directors of HPS Laboratories Private Limited
HPS Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnuvardhan Reddy Devireddy Also directs: Popular Molecules Private Limited, Konar Organics Limited, Norrish Laboratories Private Limited and 1 more | Director | 05 Dec 2017 | 8 Years 10 Months | Current |
| Mallikarjuna Reddy Venati Also directs: Popular Molecules Private Limited, Konar Organics Limited, Norrish Laboratories Private Limited and 1 more | Director | 23 Mar 2006 | 20 Years 7 Months | Current |
| Padma Duvvuri | Director | 23 Mar 2006 | 20 Years 7 Months | Current |
Peer comparison
HPS Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auro Peptides Limited | ₹23.52 Cr (FY 2025) | -14.0% | Hyderabad, Telangana, India | |||
| Medisol Lifescience Private Limited | ₹23.51 Cr (FY 2024) | 158.0% | Mumbai, Maharashtra, India | |||
| Bini Laboratories Private Limited | ₹23.43 Cr (FY 2024) | -16.0% | Mumbai, Maharashtra, India | |||
| Precept Pharma Limited | ₹23.38 Cr (FY 2025) | -6.0% | Chandigarh, India | |||
| Alvista Biosciences Private Limited | ₹23.38 Cr (FY 2025) | 146.0% | New Delhi, Delhi, India | |||
| HPS Laboratories Private Limitedthis company | ₹23.36 Cr (FY 2025) | -₹57.72 Lakh | -2.5% | -3.0% | Hyderabad, Telangana, India | |
| Govind Laboratories Private Limited | ₹23.3 Cr (FY 2024) | 92.0% | Ahnedabad, Gujarat, India | |||
| Health Line Pharmaceuticals Private Limited | ₹23.25 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Go-Ish Remedies Limited | ₹23.23 Cr (FY 2025) | 16.0% | Nalagarh, Himachal Pradesh, India | |||
| Medisky Pharmaceuticals Private Limited | ₹23.22 Cr (FY 2024) | 196.0% | Ahmedabad, Gujarat, India | |||
| Atman Pharma Private Limited | ₹23.16 Cr (FY 2025) | Mumbai, Maharashtra, India |
To see the full peer comparison of HPS Laboratories Private Limited, buy the company report.
Auditor
HPS Laboratories Private Limited is audited by G.R.VENKATESAN & COMPANY for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.R.VENKATESAN & COMPANY | FY 2020 | 042631S |
Shareholding
The shareholding of HPS Laboratories Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of HPS Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Mar 2013 | 10422373 | State Bank of India | ₹3.35 Cr | Satisfied |
To see the full charge records of HPS Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving HPS Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HPS Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
HPS Laboratories has 2 subsidiary companies. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Popular Polypack Private Limited | U24100TG1992PTC013648 | |
| Konar Organics Limited | U24230TG1988PLC008215 |
To see the full group structure of HPS Laboratories Private Limited, buy the company report.
GST
No GST registration is on our record for HPS Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
HPS Laboratories Private Limited has 4 board changes on record since 2006: 3 appointments and 1 cessation. The latest: Vishnuvardhan Reddy Devireddy ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
HPS Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 2006 (20+ years old) and is registered under CIN U24239TG2006PTC049581.
HPS Laboratories has 3 current directors:
- Vishnuvardhan Reddy Devireddy - Director
- Mallikarjuna Reddy Venati - Director
- Padma Duvvuri - Director
The latest financial statements of HPS Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of HPS Laboratories is U24239TG2006PTC049581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HPS Laboratories was incorporated on 23 March 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of HPS Laboratories by revenue are Auro Peptides Limited, Medisol Lifescience Private Limited, Bini Laboratories Private Limited, Precept Pharma Limited, Alvista Biosciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Vishnuvardhan Reddy Devireddy ceased to be Additional Director on 29 Sep 2018. Vishnuvardhan Reddy Devireddy was appointed as Director on 05 Dec 2017. Mallikarjuna Reddy Venati was appointed as Director on 23 Mar 2006. HPS Laboratories has 4 board changes on record in total.
The registered office of HPS Laboratories is at Shed No: 41 Phase – II I.D.A Mallapur, Hyderabad, Telangana, India – 500076.
HPS Laboratories operates in the pharma industry, in the drug formulation and development segment.
HPS Laboratories has no open charges and satisfied charges of ₹3.35 Cr as per latest MCA filings.
The compliance status of HPS Laboratories is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.